Kevan Herold, MD
C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)Cards
About
Research
Overview
The pathogenesis and treatment of autoimmune disease, in particular Type 1 diabetes.
Studies involve clinical trials with patients and investigations of the mechanism of action of immune therapies and the pathogenesis of disease in patients as well as in animal models when needed to address what cannot be studies in humans. Over the past 7 years, our lab has carried out trials of a humanized non-FcR binding anti-CD3 monoclonal antibody in patients and has studied the mechanism of drug action. These clinical studies have suggested novel mechanisms of immune regulation that are now to be addressed with new clinical studies.
Medical Research Interests
Public Health Interests
Clinical Care
Overview
Kevan Herold, MD, is an endocrinologist who treats adult and child patients with type 1 and type 2 diabetes, diabetes that occurs after therapies for cancer, and hypoglycemia (low blood glucose levels).
Type 1 diabetes is an autoimmune disease that is often diagnosed in children and teens. The immune system mistakenly attacks healthy body tissues and destroys cells in the pancreas that produce insulin.
Dr. Herold’s goal is to better understand the mechanisms for type 1 diabetes in order to develop new treatments for his patients. His research revolves around beta cell function. In type 1 diabetes, beta cells produce little or no insulin and are destroyed by T cells from the immune system. Dr. Herold and his lab also research autoimmune diabetes development in cancer patients.
Recently, Dr. Herold was the principal investigator for a clinical trial that showed the effectiveness of teplizumab, a new drug that could delay type 1 diabetes development by two years. He is chair of NIDDK (National Institute of Diabetes and Digestive Diseases) TrialNet, an international network of type 1 diabetes researchers.
Dr. Herold is C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology) at Yale School of Medicine.
Clinical Specialties
Fact Sheets
Hyperglycemia: Symptoms, Causes, and Treatments
Learn More on Yale MedicineHemoglobin A1C Test
Learn More on Yale MedicineDiabetes: Symptoms, Causes, and Treatments
Learn More on Yale MedicineType 2 Diabetes: Symptoms and Treatments
Learn More on Yale Medicine
Board Certifications
Endocrinology & Metabolism
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1985
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1982
Yale Medicine News
News & Links
News
- November 01, 2024Source: LiveScience.com
In a 1st, scientists reversed type 1 diabetes by reprogramming a person's own fat cells
- August 01, 2024
Meet Yale Internal Medicine: Ana Luisa Perdigoto, MD, PhD
- March 20, 2024
From the journals
- December 14, 2023Source: Hartford Courant
A New Diabetes Drug Could Push Off Insulin Use for Years. A CT Boy Who Is Afraid of Needles Is Trying It.